Macrophages and monocytes in liver cirrhosis – beyond immunity
Prof. Dr. med. Christine Bernsmeier, University of Basel, Department of Biomedicine, Basel, Switzerland
Transjugular intrahepatic portosystemic shunt – emerging indications and prognostic impact in decompensated liver cirrhosis
Prof. Dr. med. Virginia Hernández-Gea, Liver Unit, Hospital Clinic-IDIBAPS Barcelona, Spain
Gut barrier impairment in ALD pathogenesis
Professor Shilpa Chokshi, the Roger Williams Institute of Hepatology, London, UK
Targeting the gut microbiota to treat ALD
Professor Peter Stärkel, Institute of Experimental and Clinical Research Université Catholique de Louvain, Belgium
The Role of Artificial Intelligence in HCC as a Tool for Diagnosis and Prognosis
Professor Dr. med. Julien Calderaro, Henri Mondor University Hospital, Department of Pathology, Creteil, France
Tailored Therapy in advanced Hepatocellular Carcinoma – current status and future directions
Professor Dr. med. Massimo Alberto lavarone, Policlinico di Milano, Gastroenterology and Hepatology, Milano, Italy
How to distinguish hereditary haemochromatosis from other high ferritin diseases
Professor John Ryan, Hepatology and Gastroenteroloy, Beaumont Hospital, Dublin, Ireland
Cholemic nephropathy: From pathomechanism to potential treatment options
Professor Dr. Ahmed Ghallab, Head Intravital Toxicology Group, Leibniz Institute for Occupational Research at TU Dortmund, Dortmund, Germany
Treatment of autoimmune hepatitis: beyond azathioprine
Prof. Dr. med. George Dalekos, University of Thessaly, Faculty of Health Sciences, Medical School, Biopolis, Larissa, Greece
Novelties in hepatitis B and D
Prof. Dr. med. Maria Buti, Hospital Universitario Valle Hebron, Barcelona, Spain
MASLD/MASH and Diabetes: a synergic Impact
Prof. Dr. Michael Roden, Chairman and Full Professor of internal medicine Endocrinology and Metabolic Diseases at Heinrich-Heine University, Director of the Division of Endocrinology and Diabetology at University Clinics Düsseldorf and Chief Scientific Ex
MASH - Liver-specific Therapy
Prof. Dr. Sven Francque, Chairman of the Department of Gastroenterology and Hepatology of the University Hospital Antwerp and Full Professor of Medicine at the Faculty of Medicine and Health Sciences of the University of Antwerp, Belgium
Cookie und Datenfreigabe Einstellung
Auf unserer Website verwenden wir Cookies und Anwendungen von Drittanbietern, um einen optimalen Online-Service zu gewährleisten. Um Ihre Privatsphäre zu schützen können Sie diese Anwendungen hier kontrollieren und verwalten.
Für weitere Informationen lesen Sie bitte unsere Datenschutzerklärung.
